TFF3 and type III hypersensitivity disease: As FIP is an immune complex disease (Addie et al., 2003; Berry, 2001), one can speculate that suppressing the expression of proteins such as IAP and TFF‐3 and stimulating the expression of proteins such as I‐FABP may affect disease progression.